Clinical trial
Simvastatin in Preventing a New Breast Cancer in Women at High Risk for a New…
NCT00334542 · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Other · Completed
Key facts
| NCT number | NCT00334542 |
|---|---|
| Title | Simvastatin in Preventing a New Breast Cancer in Women at High Risk for a New Breast Cancer |
| Official title | A Phase II Study of Simvastatin in Women at High Risk for a New Breast Cancer |
| Lead sponsor | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | simvastatin |
| Enrollment | 50 |
| Start date | Mar 1, 2006 |
| Primary completion | Jun 1, 2009 |
| Completion | Nov 1, 2011 |
| First posted | Jun 8, 2006 |
| Last update posted | Apr 3, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: